Photodynamic Therapy Targeting Matrix Metalloproteases in Cancer: Standpoint for an Innovative Anticancer Strategy

Area of Science:

• Oncology
• Biochemistry
• Pharmacology

Background:

• Matrix metalloproteinases (MMPs) are crucial enzymes implicated in cancer growth and metastasis.
• Photodynamic therapy (PDT) is a localized cancer treatment that can influence MMP activity.
• Current MMP inhibitors show limited clinical efficacy, necessitating novel therapeutic strategies.

Purpose of the Study:

• To review recent advances in targeting cancer-related MMPs as therapeutic targets.
• To explore innovative approaches for MMP inhibition in cancer therapy.
• To discuss the interplay between PDT and MMPs and the potential of combination therapies.

Main Methods:

• Literature review of recent research on MMPs in cancer.
• Analysis of novel MMP inhibitor (MMPI) designs and preclinical study outcomes.
• Evaluation of PDT's effects on MMPs and combined therapeutic strategies.

Main Results:

• While some small-molecule MMP inhibitors have failed in clinical trials, novel complex MMPIs show high preclinical efficacy.
• PDT can influence MMPs, sometimes activating them, but MMP inhibitors like Prinomastat can improve PDT outcomes.
• Combining therapies targeting MMPs and utilizing PDT presents an opportunity to enhance anti-cancer efficacy.

Conclusions:

• Targeting cancer-related MMPs remains a significant area for therapeutic development.
• Novel MMPIs with complex structures demonstrate promise in preclinical settings.
• Combination strategies involving MMP inhibition and PDT warrant further investigation for improved cancer treatment.